Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Nervous system drugs >  Cholinergic drugs >  Neostigmine Methyl Sulfate

Neostigmine Methyl Sulfate

Basic information Safety Supplier Related

Neostigmine Methyl Sulfate Basic information

Product Name:
Neostigmine Methyl Sulfate
Synonyms:
  • A sulfuric acid neostigmine
  • (3-(dimethylcarbamoyloxy)phenyl)trimethyl-ammoniumethylsulfate
  • (3-hydroxyphenyl)trimethylammoniummethylsulfatedimethylcarbamicester
  • (m-hydroxyphenyl)trimethylammoniummethylsulfatedimethylcarbamate
  • PROSTIGMINE
  • NEOSTIGIMINE BROMIDE
  • NEOSTIGMINE METHYL SULFATE
  • NEOSTIGMINE METHYL SULPHATE
CAS:
51-60-5
MF:
C12H19N2O2.CH3O4S
MW:
334.39
EINECS:
200-109-5
Product Categories:
  • Amines
  • Sulfur & Selenium Compounds
  • Alkaloids
  • Ammonium Polyhalides, etc. (Quaternary)
  • Quaternary Ammonium Compounds
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • 51-60-5
Mol File:
51-60-5.mol
More
Less

Neostigmine Methyl Sulfate Chemical Properties

Melting point:
175-177 °C(lit.)
storage temp. 
-20°C
solubility 
H2O: 1 g/mL
form 
powder
color 
white
Water Solubility 
1g/10mL
Merck 
14,6464
InChI
InChI=1S/C12H19N2O2.CH4O4S/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5;1-5-6(2,3)4/h6-9H,1-5H3;1H3,(H,2,3,4)/q+1;/p-1
InChIKey
OSZNNLWOYWAHSS-UHFFFAOYSA-M
SMILES
C1(OC(=O)N(C)C)C=CC=C([N+](C)(C)C)C=1.S([O-])(=O)(=O)OC
CAS DataBase Reference
51-60-5(CAS DataBase Reference)
More
Less

Safety Information

Hazard Codes 
T+
Risk Statements 
28-36/37/38-42/43-26/27/28
Safety Statements 
36-45-36/37/39-28A
RIDADR 
UN 2811 6.1/PG 2
WGK Germany 
3
RTECS 
CY1225000
HazardClass 
6.1(a)
PackingGroup 
II
HS Code 
29242990
Toxicity
LD50 in mice (mg/kg): 0.16 i.v.; 0.42 s.c.; 7.5 orally, (Randall, Lehmann)

MSDS

More
Less

Neostigmine Methyl Sulfate Usage And Synthesis

Description

Neostigmine is a reversible inhibitor of acetylcholinesterase (AChE; Kd = 260 μM). In a rat model of knee joint inflammation, intrathecal administration of neostigmine (2-30 μg) increases endogenous acetylcholine levels and dose-dependently increases the latency of paw withdrawal in response to thermal and mechanical stimuli (ED50s = 6.6 and 3.5 μg, respectively). Neostigmine (5 μg, i.p.) restores muscle action potentials in mice with a thymopoietin-induced neuromuscular block. Formulations containing neostigmine have been used in the treatment of myasthenia gravis and Ogilvie syndrome.

Chemical Properties

Crystalline Solid

Uses

Cholinergic; miotic; antidote (curare)

Definition

ChEBI: Neostigmine methyl sulfate is an arylammonium sulfate salt. It has a role as an EC 3.1.1.8 (cholinesterase) inhibitor.

brand name

Prostigmine (ICN).

General Description

Neostigmine methylsulfate,(m-hydroxyphenyl)trimethylammonium methylsulfatedimethylcarbamate or the dimethylcarbamic ester of 3-hydroxyphenyltrimethylammoniummethylsulfate (Prostigminmethylsulfate), is a bitter, odorless, white, crystalline powder.It is very soluble in water and soluble in alcohol. Solutionsare stable and can be sterilized by boiling. The compound istoo hygroscopic for use in a solid form and thus is alwaysused as an injection. Aqueous solutions are neutral to litmus.

Clinical Use

The methylsulfate salt is used postoperatively as a urinarystimulant and in the diagnosis and treatment of myastheniagravis.

Synthesis

16088-19-0

77-78-1

51-60-5

Example 9 Preparation of neostigmine methyl sulfate (general procedure) To a 250 mL four-necked round-bottomed flask was added 3-(dimethylamino)phenyldimethylcarbamate and acetone obtained in Example 1. Dimethyl sulfate (1.66 eq.) was added dropwise to the flask at room temperature. The reaction mixture was stirred overnight and then cooled to 5 °C to 10 °C and kept for 2 hours. This was followed by filtration and the filtrate was washed with isopropanol. The residue was dried under vacuum at room temperature to give the crude product neostigmine methyl sulfate. Purification was carried out by recrystallization from isopropanol. Yield: 85%. Properties: light yellow oil HPLC Purity: 99.21%.

Purification Methods

Crystallise the sulfate from EtOH or Me2CO (m 143-144o). Its solubility in H2O is ~10%. [Beilstein 13 III 939.] (It is cholinergic and highly TOXIC.)

References

[1] Patent: WO2012/131699, 2012, A1. Location in patent: Page/Page column 15
[2] Pharmazie, 2001, vol. 56, # 2, p. 181 - 182
[3] Zhurnal Prikladnoi Khimii (Sankt-Peterburg, Russian Federation), 1941, vol. 14, p. 524,526
[4] Chem.Abstr., 1942, p. 3159
[5] Patent: CH208883, 1938,

Neostigmine Methyl SulfateSupplier

Shanghai Gukang Biotechnology Co., LTD Gold
Tel
13564510648
Email
2985380065@qq.com
Wuhan Xinru Chemical Co., Ltd. Gold
Tel
15927387915 15337108568
Email
2769903731@qq.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Meryer (Shanghai) Chemical Technology Co., Ltd.
Tel
4006356688 18621169109
Email
market03@meryer.com
TCI (Shanghai) Development Co., Ltd.
Tel
021-67121386
Email
Sales-CN@TCIchemicals.com